Document Detail

Primary malignant bone neoplasm: a case report of dedifferentiated chondrosarcoma in the rib and review of the literature.
MedLine Citation:
PMID:  20979697     Owner:  NLM     Status:  MEDLINE    
Dedifferentiated chondrosarcoma (DDCS) is a rare but highly malignant primary bone neoplasm, which is resistant to radiotherapy and chemotherapy. There remains uncertainly as to the best treatment of this disease and how to improve its prognosis. In this paper we reported a case of DDCS and reviewed the related literatures in order to provide references to throw a light on the histogenesis, diagnosis and therapy of this disease.
Jin-Rong Lin; Wei-Min Zhang; Zhuo-Cai Wang
Related Documents :
17499347 - Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid ...
6679617 - Indications of an increase of occupational pleural mesothelioma in japan.
7674447 - Malignant fibrous histiocytoma of the larynx: case report and literature review.
7560457 - Erythema gyratum repens unassociated with underlying malignancy.
18368407 - Polyarteritis nodosa presenting as pancytopenia: case report and review of the literature.
22121847 - Review of attachment, play, and authenticity: a winnicott primer.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Chinese journal of cancer     Volume:  29     ISSN:  1000-467X     ISO Abbreviation:  Chin J Cancer     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-28     Completed Date:  2012-02-16     Revised Date:  2013-02-12    
Medline Journal Info:
Nlm Unique ID:  101498232     Medline TA:  Chin J Cancer     Country:  China    
Other Details:
Languages:  eng     Pagination:  964-8     Citation Subset:  IM    
Oncology Department, Guangzhou General Hospital of PLA, Guangzhou, Guangdong 510010, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Neoplasms / drug therapy,  pathology,  radionuclide imaging*
Chondrosarcoma / drug therapy,  pathology,  radionuclide imaging*
Cisplatin / administration & dosage
Doxorubicin / administration & dosage,  analogs & derivatives
Follow-Up Studies
Hemangioendothelioma / drug therapy,  radionuclide imaging,  secondary*
Lung Neoplasms / drug therapy,  radionuclide imaging,  secondary*
Methotrexate / administration & dosage
Positron-Emission Tomography and Computed Tomography
Reg. No./Substance:
15663-27-1/Cisplatin; 23214-92-8/Doxorubicin; 59-05-2/Methotrexate; 72496-41-4/pirarubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
Next Document:  Anti-cancer effects of Phyllanthus urinaria and relevant mechanisms.